• Home
  • News & IR
  • News
Company News
디엑스앤브이엑스, 지오영과 타액용 진단키트 약국 공급
2022-05-16
Company News
디엑스앤브이엑스 "3년 만에 영업이익 흑자전환"
2022-05-13
Bio Vaccine
New vaccine to treat cancer is now being trialled in Britons with prostate, lung and ovarian tumours
2022-05-10
Diagnostics
Molecular Profiling Advances Diagnosis, Treatment of Skin Diseases
2022-04-15
Company News
Global Vaccine Hub「KHUB Science Park」Full-scale Promotion in Pohang City
2022-04-13
Gene Analysis
내 유전자만 고려한 ‘맞춤약’ 시대 열릴까
2022-04-11
Diagnostics
코로나19 변이 감염도 현장에서 빠르게 진단한다
2022-04-04
Bio Vaccine
복지부, 국제백신연구소, 백신 개발 · 바이오인력양성 등 협력
2022-04-01
Gene Analysis
악성 뇌종양 ‘교모세포종’ 원인 면역유전자 확인
2022-03-24
  1.   
  2. 31
  3. 32
  4. 33
  5. 34
  6. 35
  7. 36
  8. 37
  9.   
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.